Latest

alpha-synuclein

Featured Genetics Neurology Neuroscience

·February 2, 2022·4 min read

New Non-Mutated Protein Linked to Dementia

APOE proteins were enhanced in the brains of patients with dementia, even when they did not carry the Alzheimer's associated gene.

Featured Neurology Neuroscience

·December 14, 2021·3 min read

COVID Protein Interacts With Parkinson’s Protein, Promotes Amyloid Formation

The COVID causing SARS-CoV-2 protein interacts with alpha-synuclein, speeding up the formation of amyloid plaques, a new study reports.

Featured Neurology Neuroscience

·September 22, 2021·4 min read

Immune Cells in the Brain Share the Work

Microglia immune cells can join together to form networks when needed, a new study reports. However, certain mutations associated with Parkinson's disease can impair this process.

Featured Neurology Neuroscience

·September 8, 2021·2 min read

New Information on the Early Stages of Dementia With Lewy Bodies

New findings reinforce the idea that dementia with Lewy bodies can be pathologically classified as two different and distinct disease types.

Featured Neurology Neuroscience

·June 10, 2021·6 min read

Understanding Gut Inflammation May Hold Clues to Mitigating Parkinson’s Onset

Chronic gut inflammation can trigger the clumping of alpha-synuclein in the walls of the colon, a new study reports. Researchers found chronic inflammation in the gut during early life can exacerbate the clumping of alpha-synuclein in the brains of older mice. The findings add to a growing body of evidence which links gut health to Parkinson's disease.

Featured Neurology Neuroscience

·April 28, 2021·7 min read

New Model May Explain the Mystery of Asymmetry in Parkinson’s Disease

A new model of Parkinson's disease sheds light on the asymmetrical motor symptoms, and other disorders, associated with this disease.

This is a computerized representation of a neuron

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·February 10, 2021·4 min read

Function Identified of ‘Mystery Protein’ That Kills Brain Cells of People With Parkinson’s

Study sheds new light on the damage alpha-synuclein does to neurons in Parkison's disease patients.

Featured Genetics Neurology Open Neuroscience Articles

·August 23, 2020·4 min read

Unique Protein Structures Could Hold the Key to Parkinson’s Disease

Researchers have discovered a series of misfolded alpha-synuclein protein structures never previously observed. The alpha-synuclein fibers were larger than previously reported and adopted a striking variety of shapes. The work lays the foundation for a detailed analysis of misfolded alpha-synuclein structures and could provide a better understanding of the neurobiology of Parkinson's disease.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 30, 2020·3 min read

Researchers unravel protein mystery of three brain diseases

Researchers have identified two different shapes of alpha-synuclein associated with multiple systems atrophy (MSA) and Lewy body dementia. The structure of the protein is helical in MSA, causing the symptoms to occur more quickly and aggressively. In Lewy body dementia, the protein takes on a cylindrical form.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 20, 2020·4 min read

Further evidence autoimmunity plays a role in Parkinson’s disease

T cells that react to alpha-synuclein are most abundant in the early stages of Parkinson's disease but tend to disappear as the disease progresses. Signs of autoimmunity can appear in Parkinson's patients up to ten years before a diagnosis of the neurodegenerative disease. The detection of T cell response could be an early biomarker for Parkinson's, long before the physical symptoms begin to manifest.

Featured Neurology Neuroscience

·March 13, 2020·5 min read

‘Natural killer’ cells could halt Parkinson’s progression

Natural killer cells may play a critical role in regulating and restraining neuroinflammation and protein clumping associated with Parkinson's disease.